Regorafenib effects on human colon carcinoma xenografts monitored by dynamic contrast-enhanced computed tomography with immunohistochemical validation - Wikidata - awgldk - TriplyDB

Regorafenib effects on human colon carcinoma xenografts monitored by dynamic contrast-enhanced computed tomography with immunohistochemical validation

Regorafenib effects on human colon carcinoma xenografts monitored by dynamic contrast-enhanced computed tomography with immunohistochemical validation

http://www.wikidata.org/entity/Q35010176

about

Management of regorafenib-related toxicities: a review Monitoring early response to anti-angiogenic therapy: diffusion-weighted magnetic resonance imaging and volume measurements in colon carcinoma xenografts Regorafenib in metastatic colorectal cancer.Contrast-Enhanced Ultrasound with VEGFR2-Targeted Microbubbles for Monitoring Regorafenib Therapy Effects in Experimental Colorectal Adenocarcinomas in Rats with DCE-MRI and Immunohistochemical Validation.miR-21 improves the neurological outcome after traumatic brain injury in rats.Correlation of perfusion MRI and 18F-FDG PET imaging biomarkers for monitoring regorafenib therapy in experimental colon carcinomas with immunohistochemical validation.Monitoring Cell Death in Regorafenib-Treated Experimental Colon Carcinomas Using Annexin-Based Optical Fluorescence Imaging Validated by Perfusion MRI.Clinical Implication of Anti-Angiogenic Effect of Regorafenib in Metastatic Colorectal Cancer The preclinical development of regorafenib for the treatment of colorectal cancer.An update on the safety and efficacy of regorafenib in the treatment of solid cancers.Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.Dual-energy computed tomography for the assessment of early treatment effects of regorafenib in a preclinical tumor model: comparison with dynamic contrast-enhanced CT and conventional contrast-enhanced single-energy CT.Radiological imaging markers predicting clinical outcome in patients with metastatic colorectal carcinoma treated with regorafenib: post hoc analysis of the CORRECT phase III trial (RadioCORRECT study).Translational research and application of basic biology to clinical trial development in GI cancers.

P2860

Q26795561-8397F6AF-3A50-4FAC-883D-8905A30CC6A3 Q27348906-22A3E2B7-DF1D-4155-B92B-BCAFE23E6523 Q27852864-6B2824FD-1C28-4128-8E18-53921503A340 Q30365404-CF14F1DF-2B96-4251-8C73-9754B072D276 Q30596128-C4CB5168-0C11-4564-AE1B-CE66FAA11BC6 Q35068706-CFD3F3A5-77BF-42D5-B291-8EAD855F940B Q35783407-43E31554-3731-41E6-BF1B-38FA9D6151F1 Q35869753-7233D4F9-AD67-43AC-A95F-0A96534A2D86 Q38217516-39C34A38-91A0-4B84-9292-689CF8912019 Q38260324-99474285-E57E-4737-9AA1-EF7744B5ABCE Q38498207-30F003BD-4014-4040-9D74-CEB9C86E501E Q52876610-4EF4FCA0-6602-4CC7-9659-4F7B4DD7101F Q54002435-042EB07C-6BB7-485B-8466-4125070E2D10 Q55330265-1AAA1429-32A9-4C07-87F5-1BDCCF24F829

P2860

Regorafenib effects on human colon carcinoma xenografts monitored by dynamic contrast-enhanced computed tomography with immunohistochemical validation

http://www.wikidata.org/entity/Q35010176

description

2013 nî lūn-bûn

@nan

2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Regorafenib effects on human c ...... immunohistochemical validation

@ast

Regorafenib effects on human c ...... immunohistochemical validation

@en

type

label

Regorafenib effects on human c ...... immunohistochemical validation

@ast

Regorafenib effects on human c ...... immunohistochemical validation

@en

prefLabel

Regorafenib effects on human c ...... immunohistochemical validation

@ast

Regorafenib effects on human c ...... immunohistochemical validation

@en

P1433

Q35010176-0E4A45D2-120A-4312-8AF1-5B100D2B63A1

P1476

Q35010176-0DE1E19B-2ACC-4DA0-BA5A-E0AD4C018897

P2093

Q35010176-1F1BC4FE-45D8-45DA-8593-7F2A3F76A761

Q35010176-4C49EDB8-D8CD-446D-BADA-9C865408A75B

Q35010176-5D81E82D-5968-4DA7-9717-E64F051CA383

Q35010176-62F77873-5BD1-4C75-8121-58D7A6B87A06

Q35010176-65FF00F6-B04D-44F6-876B-F5A69ECAEBC0

Q35010176-6C8CB9E6-BBAA-4271-9741-2ECD3F083518

Q35010176-6D60EF9D-27A8-4FEA-9265-F6F08D71F9BA

Q35010176-BEA0E0DD-EEA0-4863-B5C4-C5542E4F2E88

Q35010176-CB6DE669-AFD6-418C-A2CF-0CCF78EA05D6

Q35010176-F56EE605-C7BE-4375-8665-C78D8D149A04

P2860

Q35010176-01013CEB-B7D2-4074-8FC0-9A59F6CA3869

Q35010176-0993985F-1BE7-4517-94DE-8D5DD34E402D

Q35010176-0DB7C21E-ABA3-4F70-80AA-3F1E73F928C7

Q35010176-27103935-3EBD-4A25-9386-9B0ED691A09C

Q35010176-37B40053-6E49-4960-A4A9-4B5AC4F6FF9D

Q35010176-3F8E76EF-567D-496C-BE6A-D5C00DD8CD26

Q35010176-44706597-533A-4333-90FC-80E4A0AE3797

Q35010176-52D7A3C9-F055-48DF-8888-51C7C752C239

Q35010176-539C2534-80B3-46A2-81A1-C1F7817DF447

Q35010176-6446CE8E-2557-4EF0-AB6D-C873747BB44B

P304

Q35010176-545A04BA-D217-4CC8-92BC-7CE2D8A6DDCD

P31

Q35010176-B93D7D40-1289-42B6-AA15-FD9DDDF9BD71

P356

Q35010176-AC777237-33B7-40C4-813D-4109B226D6C7

P407

Q35010176-E4CF0419-17F9-4CD2-9BF8-BA0C6BC6130B

P433

Q35010176-B5C41D21-479C-44ED-A026-D76A1B5DD529

P478

Q35010176-2E9D0593-00A8-4AC7-8443-5D5147FE14F3

P50

Q35010176-8793AAC8-9024-483C-98FD-A692E15D0F6E

Q35010176-D643E304-30D6-4764-B03C-00B860AE7767

P577

Q35010176-83CBA478-F119-4B77-BDD3-FE2D0E290F5A

P5875

Q35010176-3A44C56A-E143-4A4F-99AC-CA55A34F88E4

P698

Q35010176-04F6FCC9-30AA-4668-BA59-BD4D49959A29

P921

Q35010176-40A435C9-52B5-4F5C-BBAD-5D51D9C4FD22

Q35010176-7B8DC8DA-8D32-44FD-AD65-34401251C0EB

P932

Q35010176-35FF6D14-8CB5-46D2-BD26-E848BDF5DFD6

P356

JOURNAL.PONE.0076009

P1433

P1476

Regorafenib effects on human c ...... immunohistochemical validation

@en

P2093

Alexandra Michels

http://www.w3.org/2001/XMLSchema#string

Bettina Schwarz

http://www.w3.org/2001/XMLSchema#string

Christiane J Bruns

http://www.w3.org/2001/XMLSchema#string

Clemens C Cyran

http://www.w3.org/2001/XMLSchema#string

Heidrun Hirner

http://www.w3.org/2001/XMLSchema#string

Lukas Havla

http://www.w3.org/2001/XMLSchema#string

Matthias Moser

http://www.w3.org/2001/XMLSchema#string

Maximilian F Reiser

http://www.w3.org/2001/XMLSchema#string

Philipp M Kazmierczak

http://www.w3.org/2001/XMLSchema#string

Ralf Eschbach

http://www.w3.org/2001/XMLSchema#string

P2860

Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial

Imaging beyond RECIST: CT and MRI in molecular therapies

In vivo monitoring of angiogenesis inhibitory treatment effects by dynamic contrast-enhanced computed tomography in a xenograft tumor model.

Assessment of acute antivascular effects of vandetanib with high-resolution dynamic contrast-enhanced computed tomographic imaging in a human colon tumor xenograft model in the nude rat

Evaluation of the microcirculation of hepatocellular carcinomas using contrast-enhanced ultrasound with intraarterial and intravenous contrast application during transarterial chemoembolization with drug-eluting beads (DEB-TACE): preliminary data.

Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment?

Update on antiangiogenic therapy in colorectal cancer: aflibercept and regorafenib.

Integrated 18F-fluorodeoxyglucose-positron emission tomography/dynamic contrast-enhanced computed tomography to phenotype non-small cell lung carcinoma

Prognostic value of different CT measurements in early therapy response evaluation in patients with metastatic colorectal cancer

P304

e76009

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0076009

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Konstantin Nikolaou

Michael Ingrisch

P577

2013-09-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257464961

http://www.w3.org/2001/XMLSchema#string

P698

24098755

http://www.w3.org/2001/XMLSchema#string

P921

immunohistochemistry

P932

3786893

http://www.w3.org/2001/XMLSchema#string